September 13, 2024

Supplementary Data 1 from Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma

Los puntos clave no están disponibles para este artículo en este momento.

Individual whole slide images of HNSCC PDX tumor used for TME analysis.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Lim et al. (Fri,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Preguntar a la IA

Me gusta

Guardar